ArticleExperimental hematology & oncology2025

The lncRNA PARylator promotes PARP1 activation and resistance to DNA‑damaging therapy in esophageal squamous cell carcinoma.

Teng Fei Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.